PuSH - Publikationsserver des Helmholtz Zentrums München


46 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
Lombardo, E.* et al.: DeepClassPathway: Molecular pathway aware classification using explainable deep learning. Eur. J. Cancer 176, 41-49 (2022)
Issels, R.D.* et al.: Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial. Eur. J. Cancer 158, 123-132 (2021)
Benmebarek, M.* et al.: Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models. Eur. J. Cancer 110, S3-S3 (2019)
Freudenreich, M.* et al.: Clinical relevance of in vitro generated dendritic cells of leukemic origin to predict response to immunotherapy in patients with AML and MDS. Eur. J. Cancer 110, S29-S29 (2019)
Merle, M.* et al.: Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts the (serum) chemokine-release profile to a more 'inflammatory' (in culture) going along with improved antileukemic T-cell-reactivity. Eur. J. Cancer 110, S24-S24 (2019)
Fröhlich, F. et al.: Large-scale modeling of cancer signaling: Mechanistic modeling meets Big Data. Eur. J. Cancer 68, S44-S44 (2016)
Hensel, T.* et al.: Inhibition of BET bromodomain proteins and the PI3K pathway in Ewing sarcoma down regulates the specific transcriptional program, inhibits tumorigenicity and increases apoptosis in Ewing sarcoma. Eur. J. Cancer 68, S48-S48 (2016)
Luber, B.* et al.: Identification of predictive response and resistance factors to targeted therapy in gastric cancer using a systems medicine approach. Eur. J. Cancer 68, S135-S135 (2016)
Tinhofer, I.* et al.: Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation. Eur. J. Cancer 57, 78-86 (2016)
Vergalli, J. et al.: X-Linked inhibitor of apoptosis protein (XIAP) exhibits an essential role of patients' acute lymphoblastic leukemia cells growing in vivo. Eur. J. Cancer 68, S58-S59 (2016)
von Heyking, K.* et al.: The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma. Eur. J. Cancer 68, S47-S47 (2016)
Gimenez-Aznar, I. et al.: Fanconi anemia, complementation group A (FancA) overexpression confers radioresistance to oral keratinocytes. Eur. J. Cancer 51, S121 (2015)
Neff, F.* et al.: Notch triggers myeloid reprogramming in murine pancreatic cancer. Eur. J. Cancer 51, S2 (2015)
Schnorfeil, F.M. et al.: Vaccination with next-generation dendritic cells for aml postremission therapy induces antigen-specific T cell responses. Eur. J. Cancer 51, S8 (2015)
Bauer, J. ; Sandhöfer, N. ; Hiddemann, W. & Spiekermann, K.: Novel FLT3 mutation shows dominant negative effects on the wild-type FLT3 receptor. Eur. J. Cancer 50, S121 (2014)
Burton, N.* et al.: Real time noninvasive 2D and 3D Multispectral Optoacoustic Tomography (MSOT) for clinical imaging of vessel oxygenation and melanin distribution. Eur. J. Cancer 50, S157 (2014)
Driessen, W.H.P.* et al.: Novel approaches for dynamic biomarker imaging by Multispectral Optoacoustic Tomography (MSOT). Eur. J. Cancer 50, S55 (2014)
Gimenez-Aznar, I. et al.: FancA overexpression confers radioresistance to cells of head and neck squamous cell carcinoma. Eur. J. Cancer 50, S229 (2014)
Höfig, I. et al.: Relevance of 3D-microtissues to investigate the therapeutic oncogenes HER2 and PTK6 in breast cancer. Eur. J. Cancer 50, S226 (2014)
Huber, M. et al.: uPAR and its interaction partners: potential new therapy targets in triple negative breast cancer. Eur. J. Cancer 50, S161-S162 (2014)